Showing results (91-100 of 177) with videos related to

Sort By:
Pageof 18
Journal of the Neurological Sciences|February 1, 2014
Risk factors and acute ischemic stroke subtypesAliaksei Kisialiou, Rodolfo Grella, Albino Carrizzo, et al.
Critical Reviews in Oncology/Hematology|March 8, 2022
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic reviewAlberto Servetto, Fabio Salomone, Fabrizio Di Costanzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2015
Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft ModelsTeresa Troiani, Stefania Napolitano, Giulia Martini, et al.
Frontiers in Oncology|January 12, 2019
CDK 4/6 Inhibitors as Single Agent in Advanced Solid TumorsFrancesco Schettini, Irene De Santo, Carmen G Rea, et al.
Anti-Cancer Drugs|May 23, 2013
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumorRoberto Moretto, Chiara A Cella, Lucia Raimondo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2012
Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responsesClaudio Procaccini, Veronica De Rosa, Mario Galgani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 18, 2025
siRNA for REST ameliorates symptoms in ALS mice and serum REST predicts disease prognosis and survival in ALS patientsNatascia Guida, Valeria Valsecchi, Serenella Anzilotti, et al.
British Journal of Cancer|August 11, 2023
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancerStefania Belli, Ada Pesapane, Alberto Servetto, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2024
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysisSimeone D'Ambrosio, Fabio Salomone, Filippo Vitale, et al.
Pageof 18